Balchem Corporation Announces Dividend

NEW HAMPTON, N.Y., Dec. 13, 2018 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC) today announced that on December 12, 2018, its Board of Directors declared a dividend on its shares of common stock equal to $0.47 per share, payable on January 18, 2019 to holders of record on December 26, 2018. This dividend reflects an 11.9% increase over the prior year cash dividend.

Ted Harris, Balchem’s President and CEO, stated, “Balchem has a long standing commitment to an annual dividend and we are pleased to announce the continuation of that commitment.  This dividend represents the tenth consecutive increase in our annual dividend, reflecting both the consistently outstanding financial performance the company has delivered and the Board’s continued confidence in our long-term strategies.”

Segment InformationBalchem Corporation reports four business segments: Human Nutrition & Health; Animal Nutrition & Health; Specialty Products; and Industrial Products. The Human Nutrition & Health segment delivers customized food and beverage ingredient systems, as well as key nutrients into a variety of applications across the food, supplement and pharmaceutical industries. The Animal Nutrition & Health segment manufactures and supplies products to numerous animal health markets. Through Specialty Products, Balchem provides specialty-packaged chemicals for use in healthcare and other industries, and also provides chelated minerals to the micronutrient agricultural market. The Industrial Products segment manufactures and supplies certain derivative products into industrial applications.

Forward-Looking StatementsThis release contains forward-looking statements, which reflect Balchem’s expectation or belief concerning future events that involve risks and uncertainties. Balchem can give no assurance that the expectations reflected in forward-looking statements will prove correct and various factors could cause results to differ materially from Balchem’s expectations, including risks and factors identified in Balchem’s annual report on Form 10-K for the year ended December 31, 2017. Forward-looking statements are qualified in their entirety by the above cautionary statement. Balchem assumes no duty to update its outlook or other forward-looking statements as of any future date.

Contact:Mary Ann Brush, Balchem CorporationTelephone: 845-326-5600

You May Also Be Interested In

• Hackensack Gun Crimes Attorney Adam M. Lustberg Explains NJ 2C:39-6 Firearms Exemptions
• TEAMSTERS, ALLIES RELEASE REPORT ON AMAZON VIOLATIONS OF NEW YORK WARN ACT
• DEFSEC Technologies Inc. Announces Closing of CDN$5.54 Million Private Placement